Novo Nordisk and Arogga team up to improve Diabetes Care Accessibility

Novo Nordisk Pharma Pvt. Limited and Arogga Limited have signed a Memorandum of Understanding (MoU) aimed at improving patient access to diabetes care and ensuring the availability of authentic Novo Nordisk products through digital channels in Bangladesh.

The partnership will enable Arogga to offer online ordering and home delivery services for Novo Nordisk products within Dhaka, ensuring that the products are delivered in compliance with cold-chain requirements.

In addition, Arogga will provide QR-coded instructional materials to guide patients on the correct usage of the products, said a press release.

This initiative sets a new benchmark for patient-centric innovation in Bangladesh, combining technology and accessibility while maintaining the highest compliance standards.

The signing ceremony was attended by Dr. Mohammad Riad Mamun Prodhani, Managing Director, and Dr. Mahbubur Rahman, Director of Clinical, Medical & Regulatory Affairs, from Novo Nordisk.

From Arogga Limited, Rosina Mazumder, Co-founder and Chief Executive Officer; and Yawar Mehboob, Co-founder and CSO, were present.